Stay updated on Pembrolizumab and Binimetinib in TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Binimetinib in TNBC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The clinical trial record itself remains unavailable.
    Difference
    1%
    Check dated 2026-10-25T01:39:34.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T01:28:39.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T02:05:16.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the expected study content with a standard error screen. The header and footer are visible, and the 403 message appears in the main area.
    Difference
    20%
    Check dated 2026-09-20T00:57:32.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page revision badge was updated from v3.6.5 to v3.6.6, indicating a minor maintenance/version update to the page.
    Difference
    0.1%
    Check dated 2026-08-29T21:46:55.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.6.5' was added and the previous 'Revision: v3.6.4' tag was removed, indicating an internal update to the page's versioning or formatting.
    Difference
    0.1%
    Check dated 2026-08-08T16:30:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Binimetinib in TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.